ALKS
Alkermes plc.
+0.54 (+1.17%)46.61USD449K成交股數7.8B市值122.7本益比(近四季)4.7股價營收比+27.0%營收年增(近四季)2026-10-28下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 496M+27% | 393M+28% | 385M+2% | 394M-1% | 391M+11% | 307M-19% | 378M-1% | 399M-35% | 350M | 377M | 381M | 617M |
| 營業成本 | 98.1M | 61.6M | 46.2M | 51.6M | 49.5M | 49.2M | 63.1M | 61.5M | 58.6M | 70.1M | 61.5M | 63.2M |
| 毛利 | 398M+17% | 331M+29% | 338M+7% | 343M+1% | 341M+17% | 257M-16% | 315M-1% | 338M-39% | 292M | 307M | 319M | 554M |
| 毛利率 | 80.2% | 84.3% | 88.0% | 86.9% | 87.3% | 83.9% | 83.3% | 84.6% | 83.3% | 81.4% | 83.9% | 89.8% |
| 研發費用 | 113M | 103M | 93.0M | 81.7M | 77.4M | 71.8M | 59.9M | 59.6M | 67.6M | 73.9M | 64.9M | 68.2M |
| 銷售管理費用 | 218M | 265M | 187M | 172M | 171M | 172M | 150M | 168M | 180M | 170M | 156M | 196M |
| 營業利益 | 18.4M-80% | −48.3M-450% | 58.1M-45% | 89.1M-19% | 93.0M+115% | 13.8M-75% | 105M+17% | 110M-61% | 43.3M | 54.6M | 89.2M | 281M |
| 營業利益率 | 3.7% | -12.3% | 15.1% | 22.6% | 23.8% | 4.5% | 27.7% | 27.5% | 12.4% | 14.5% | 23.4% | 45.6% |
| 稅後淨利 | 501K-99% | −66.5M-396% | 49.4M-47% | 82.8M-9% | 87.1M+136% | 22.5M-80% | 92.4M+93% | 91.4M-61% | 36.8M | 113M | 47.8M | 237M |
| 淨利率 | 0.1% | -16.9% | 12.8% | 21.0% | 22.3% | 7.3% | 24.4% | 22.9% | 10.5% | 29.9% | 12.5% | 38.4% |
| 稀釋 EPS | 0.00-100% | -0.40-408% | 0.29-47% | 0.49-8% | 0.52+148% | 0.13-81% | 0.55+96% | 0.53-62% | 0.21 | 0.69 | 0.28 | 1.38 |
| 稀釋股數 | 173M | 166M | 169M | 169M | 168M | 169M | 167M | 171M | 173M | 170M | 172M | 172M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 512M | 352M | 389M | 616M | 521M | 400M | 396M | 535M | 421M | 457M | 648M | 666M |
| 應收帳款 | 456M | 408M | 334M | 354M | 355M | 319M | 367M | 366M | 316M | 332M | 338M | 334M |
| 存貨 | 299M | 337M | 197M | 191M | 192M | 183M | 191M | 195M | 198M | 186M | 192M | 189M |
| 總資產 | 4.4B | 4.3B | 2.5B | 2.3B | 2.3B | 2.1B | 2.2B | 2.2B | 2.1B | 2.1B | 2.3B | 2.2B |
| 有息負債 | 1.5B | 1.5B | 0.00 | – | – | – | 286M | 286M | 287M | 288M | 288M | 289M |
| 總負債 | 2.6B | 2.5B | 668M | 596M | 628M | 570M | 863M | 923M | 869M | 934M | 924M | 907M |
| 股東權益 | 1.8B | 1.8B | 1.8B | 1.7B | 1.6B | 1.5B | 1.3B | 1.3B | 1.3B | 1.2B | 1.4B | 1.3B |
| 負債比 | 58.8% | 58.9% | 26.8% | 25.6% | 27.9% | 27.4% | 40.0% | 41.8% | 40.9% | 43.7% | 40.5% | 41.5% |
| 淨現金(現金 − 有息負債) | −965M | −1.1B | 389M | – | – | – | 110M | 249M | 134M | 170M | 359M | 377M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −166M-268% | – | – | – | 98.8M | – | – | 21.1M | – | – | – |
| 資本支出 | – | 4.1M | – | – | – | 10.1M | – | – | 8.3M | – | – | – |
| 自由現金流 | – | −170M-291% | – | – | – | 88.7M | – | – | 12.8M | – | – | – |
| 折舊攤銷 | – | 19.4M | – | – | – | 7.4M | – | – | 8.1M | – | – | – |
| 買回庫藏股 | – | 27.7M | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -43.2% | – | – | – | 28.9% | – | – | 3.6% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 1.5B
| 美國 | 1.4B | 93.0% | -2.7% |
|---|---|---|---|
| Foreign Country Excluding Specified Country | 102M | 6.9% | -30.0% |
| 愛爾蘭 | 754K | 0.1% | -41.7% |
產品／服務2025 年度 · 1.5B
| Vivitrol | 468M | 31.7% | +2.3% |
|---|---|---|---|
| Aristada And Aristada Initio | 370M | 25.1% | +6.9% |
| LYBALVI | 347M | 23.5% | +23.8% |
| Royalty | 245M | 16.6% | -30.8% |
| Manufacturing Revenue | 46.0M | 3.1% | -61.5% |
| 產品 小計 | 1.2B | 80.3% | +9.3% |
| Manufactured Product And Royalty 小計 | 291M | 19.7% | -38.6% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 1.5B | -5.2% | 242M | 16.4% | 1.43 | 480M |
| FY2024 | 1.6B | -6.4% | 367M | 23.6% | 2.17 | 406M |
| FY2023 | 1.7B | +49.6% | 356M | 21.4% | 2.10 | 353M |
| FY2022 | 1.1B | -5.3% | −158M | -14.2% | -0.97 | −17.2M |
| FY2021 | 1.2B | +13.0% | −48.2M | -4.1% | -0.29 | 73.7M |
| FY2020 | 1.0B | -11.3% | −111M | -10.7% | -0.70 | 40.6M |
| FY2019 | 1.2B | +7.0% | −197M | -16.8% | -1.25 | −18.9M |
| FY2018 | 1.1B | – | −139M | -12.7% | -0.90 | 29.9M |